Profiel
Leodevico L.
Ilag was the founder of Xerion Pharmaceuticals AG, serving as MD, Chief Scientific & Technology Officer from 1998 to 2004.
Dr. Ilag is currently a Non-Executive Director at Plentex Ltd. since 2021.
Former positions include Chief Operating Officer at Patrys Ltd. and Chief Scientific Officer at Manalto Ltd.
Actieve functies van Leodevico L. Ilag
| Bedrijven | Functie | Begin |
|---|---|---|
| PLENTEX LIMITED | Directeur/Bestuurslid | 22-07-2021 |
Eerdere bekende functies van Leodevico L. Ilag
| Bedrijven | Functie | Einde |
|---|---|---|
Xerion Pharmaceuticals AG
Xerion Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops antibodies and therapeutic targets | Oprichter | 01-01-2004 |
| MANALTO LIMITED | Hoofd Techniek/Wetenschap/O&O | - |
| PATRYS LIMITED | Operationeel Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Patrys Ltd.
Patrys Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibody technologies for hard-to-treat cancers | Health Technology |
Plentex Ltd.
Plentex Ltd. Agricultural Commodities/MillingProcess Industries Produces, develops and supplies algae oil to the biological and fuel industry | Process Industries |
Manalto Ltd.
Manalto Ltd. Packaged SoftwareTechnology Services Develops and commercializes social media management software | Technology Services |
Xerion Pharmaceuticals AG
Xerion Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops antibodies and therapeutic targets | Health Technology |
















